文献速递临床试验与 GCP真实世界研究与卫生经济

REACT研究方案:社区体力活动干预预防退休老年人移动相关残疾的随机对照试验

A community-based physical activity intervention to prevent mobility-related disability for retired older people (REtirement in ACTion (REACT)): study protocol for a randomised controlled trial.
PubMed 文献 · Trials · 2018-04-17

REACT是一项多中心、实用性、双臂平行组随机对照试验(含内部预试验),旨在检验社区团体体力活动干预对高移动相关残疾风险老年人功能受限进展的减缓或逆转效果及成本效果。研究拟纳入768名65岁及以上、久坐、有功能受限但可行走的社区居住老年人(SPPB评分4-9分/12分),随机接受12个月REACT干预或最小对照干预,主要结局为24个月时SPPB评分。

要点

  • REACT干预由受训指导者实施,为期12个月,针对有功能受限但尚未残疾的社区老年人。
  • 主要结局为24个月时SPPB评分,主要分析按意向性治疗(ITT)进行并重视置信区间。
  • 研究包含完整经济评价、过程评价及MRI子研究,检验干预对脑萎缩和认知功能下降的减缓作用。

核心结论

  • REACT旨在检验社区团体体力活动干预能否减缓或逆转高移动相关残疾风险老年人的功能受限进展,并评估其成本效果。

研究设计与样本

  • 多中心、实用性、双臂平行组随机对照试验,含内部预试验阶段,计划样本量768人。
  • 纳入65岁及以上、久坐、社区居住、有功能受限但仍可行走的老年人,SPPB评分4-9分(满分12分)。
  • 随机分为12个月REACT干预组(由受训指导者实施)或最小对照干预组。
  • 主要结局为24个月时SPPB评分,主要比较分析按意向性治疗(ITT)进行并重视置信区间。
  • 包含嵌套子研究,用MRI检验干预是否减缓脑萎缩速率和认知功能下降,MRI数据在基线、6、12个月收集。

关键数值与推荐

  • SPPB评分4-9分(满分12分)为纳入的功能受限标准。
  • 主要结局分析为24个月时SPPB评分,按ITT原则进行。
  • 结局数据收集时间为基线、6、12和24个月;MRI子研究数据收集时间为基线、6和12个月。

临床怎么用

  • 若REACT干预被证实有效且具成本效果,有潜力在英国及其他地区广泛实施。
  • 干预方案成功让该人群参与足够活动以改善力量、有氧能力、协调和平衡,将对维持健康和独立性产生重大影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The REtirement in ACTion (REACT) study is a multi-centre, pragmatic, two-arm, parallel-group randomised controlled trial (RCT) with an internal pilot phase. It aims to test the effectiveness and cost-effectiveness of a community, group-based physical activity intervention for reducing, or reversing, the progression of functional limitations in older people who are at high risk of mobility-related disability. METHODS/DESIGN: A sample of 768 sedentary, community-dwelling, older people aged 65 years and over with functional limitations, but who are still ambulatory (scores between 4 and 9 out of 12 in the Short Physical Performance Battery test (SPPB)) will be randomised to receive either the REACT intervention, delivered over a period of 12 months by trained facilitators, or a minimal control intervention. The REACT study incorporates comprehensive process and economic evaluation and a nested sub-study which will test the hypothesis that the REACT intervention will slow the rate of brain atrophy and of decline in cognitive function assessed using magnetic resonance imaging (MRI). Outcome data will be collected at baseline, 6, 12 and 24 months for the main study, with MRI sub-study data collected at baseline, 6 and 12 months. The primary outcome analysis (SPPB score at 24 months) will be undertaken blinded to group allocation. Primary comparative analyses will be on an intention-to-treat (ITT) basis with due emphasis placed on confidence intervals. DISCUSSION: REACT represents the first large-scale, pragmatic, community-based trial in the UK to target the non-disabled but high-risk segment of the older population with an intervention to reduce mobility-related disability. A programme that can successfully engage this population in sufficient activity to improve strength, aerobic capacity, coordination and balance would have a major impact on sustaining health and independence. REACT is also the first study of its kind to conduct a full economic and comprehensive process evaluation alongside the RCT. If effective and cost-effective, the REACT intervention has strong potential to be implemented widely in the UK and elsewhere. TRIAL REGISTRATION: ISRCTN, ID: ISRCTN45627165 . Retrospectively registered on 13 June 2016. Trial sponsor: University of Bath. Protocol Version 1.5.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Stathi A, Withall J, Greaves CJ, et al. A community-based physical activity intervention to prevent mobility-related disability for retired older people (REtirement in ACTion (REACT)): study protocol for a randomised controlled trial. Trials. 2018. PMID: 29665854. doi:10.1186/s13063-018-2603-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。